Cargando…

Proposing novel natural compounds against Alzheimer’s disease targeting acetylcholinesterase

Alzheimer’s disease (AD) is a neurodegenerative disorder considered as a global public health threat influencing many people. Despite the concerning rise in the affected population, there is still a shortage of potent and safe therapeutic agents. The aim of this research is to discover novel natural...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girgin, Münteha, Isik, Sevim, Kantarci-Carsibasi, Nigar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138233/ https://www.ncbi.nlm.nih.gov/pubmed/37104478 http://dx.doi.org/10.1371/journal.pone.0284994

Ejemplares similares

Biocomputational Screening of Natural Compounds against Acetylcholinesterase
por: Ahmad, Syed Sayeed, et al.
Publicado: (2021)

A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease
por: Peitzika, Stergiani-Chrysovalanti, et al.
Publicado: (2023)

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
por: Guo, Yan, et al.
Publicado: (2020)

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
por: dos Santos, Thaiane Coelho, et al.
Publicado: (2018)

The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer’s disease targeting acetylcholinesterase
por: Rehman, Sidra, et al.
Publicado: (2022)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
por: Atanasova, Mariyana, et al.
Publicado: (2022)

Natural Peptides in Drug Discovery Targeting Acetylcholinesterase
por: Prasasty, Vivitri, et al.
Publicado: (2018)

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
por: Son, Minky, et al.
Publicado: (2019)

N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease
por: Toiber, Debra, et al.
Publicado: (2008)

Hybrid approach to sieve out natural compounds against dual targets in Alzheimer’s Disease
por: Das, Sucharita, et al.
Publicado: (2019)

Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
por: Pourtaher, Hormoz, et al.
Publicado: (2022)

Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease
por: Semenov, Vyacheslav E., et al.
Publicado: (2020)

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
por: Zou, Dajiang, et al.
Publicado: (2023)

Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer’s Disease
por: Li, Zeng, et al.
Publicado: (2016)

Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors
por: Ferris, Steven H, et al.
Publicado: (2013)

The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
por: Vecchio, Immacolata, et al.
Publicado: (2021)

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer’s Disease
por: Wang, Shanshan, et al.
Publicado: (2022)

Tetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease
por: Montecinos-Oliva, Carla, et al.
Publicado: (2015)

Novel and Potent Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease from Natural (±)-7,8-Dihydroxy-3-methyl-isochroman-4-one
por: Li, Xinnan, et al.
Publicado: (2022)

Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease
por: Jean, Létitia, et al.
Publicado: (2007)

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2020)

Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management
por: Hakeem, Israa J
Publicado: (2023)

A Novel Application of Multiscale Entropy in Electroencephalography to Predict the Efficacy of Acetylcholinesterase Inhibitor in Alzheimer's Disease
por: Tsai, Ping-Huang, et al.
Publicado: (2015)

Development of p-Tau Differentiated Cell Model of Alzheimer’s Disease to Screen Novel Acetylcholinesterase Inhibitors
por: Uras, Giuseppe, et al.
Publicado: (2022)

Anti-Alzheimer activity of new coumarin-based derivatives targeting acetylcholinesterase inhibition
por: Kamel, Nahla N., et al.
Publicado: (2023)

Novel Acetylcholinesterase Target Site for Malaria Mosquito Control
por: Pang, Yuan-Ping
Publicado: (2006)

Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer’s Disease Target
por: Kaufmann, Dorothea, et al.
Publicado: (2016)

Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation
por: El-Hussieny, Marwa, et al.
Publicado: (2023)

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease
por: Paroni, Giulia, et al.
Publicado: (2014)

Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease
por: Toublet, François-Xavier, et al.
Publicado: (2019)

Molecular interaction of human acetylcholinesterase with trans-tephrostachin and derivatives for Alzheimer's disease
por: Pitchai, Arjun, et al.
Publicado: (2020)

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy
por: Arya, Ashwani, et al.
Publicado: (2021)

Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer’s Disease. Review of Reviews
por: Moreta, Marta Pérez-Gómez, et al.
Publicado: (2021)

Efficacy of Souvenaid(®) Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease
por: García-Alberca, José María, et al.
Publicado: (2023)

Exploring Medicinal Herbs’ Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer’s Disease Treatment
por: Farihi, Ayoub, et al.
Publicado: (2023)

Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer’s disease
por: Parween, Fauzia, et al.
Publicado: (2021)

Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer’s Disease
por: Semenov, Vyacheslav E., et al.
Publicado: (2022)

Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease
por: Du, Hongtao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lrabba05bsjal64kb315l0moud